StockData
Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc. (TARS) stock

TARSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/301% above fair value
$75.95−2.25 (-2.88%)

Close on Nov 18, 2026Market cap $3.33BP/E –Yield 0.00%

Tarsus Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Tarsus Pharmaceuticals

Tarsus Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Tarsus Pharmaceuticals figures

See a number that looks wrong?